138 related articles for article (PubMed ID: 25702620)
1. Effect of active infection on cytochrome P450-mediated metabolism of cyclosporine in renal transplant patients.
Hegazy SK; Adam AG; Hamdy NA; Khalafallah NM
Transpl Infect Dis; 2015 Jun; 17(3):350-60. PubMed ID: 25702620
[TBL] [Abstract][Full Text] [Related]
2. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
Qazi YA; Forrest A; Tornatore K; Venuto RC
Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
[TBL] [Abstract][Full Text] [Related]
3. Importance of early adequate exposure to cyclosporine in renal transplant outcome: study of 1-year creatinine.
Dominguez J; Kompatzki A; Velasco A; Turpaud F; Norambuena R; Arenas J; Pais E; Llanos R; Cortes-Monroy G
Transplant Proc; 2005 Oct; 37(8):3358-60. PubMed ID: 16298595
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
Lam H; Jeffery J; Sitar DS; Aoki FY
Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
Sugioka N; Fujimoto K; Tanaka Y; Fukushima K; Ito Y; Kokuhu T; Okamoto M; Yoshimura N; Takada K
Drug Metab Lett; 2009 Aug; 3(3):152-61. PubMed ID: 19702545
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine trough levels in renal graft recipients.
Jauhari H; Wadhawan S; Yashpal ; Kumar A
J Indian Med Assoc; 1999 Nov; 97(11):476-7. PubMed ID: 10638120
[TBL] [Abstract][Full Text] [Related]
7. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
Tinawi M; Miller L; Bastani B
Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
[TBL] [Abstract][Full Text] [Related]
8. Correlations between cyclosporine concentrations at 2 hours post-dose and trough levels with functional outcomes in de novo lung transplant recipients.
Maziers N; Bulpa P; Jamart J; Delaunois L; Eucher P; Evrard P
Transplant Proc; 2012 Nov; 44(9):2880-4. PubMed ID: 23146546
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid does not affect bioavailability of cyclosporine in renal transplant recipients.
Sud K; Muthukumar T; Singh B; Garg SK; Kohli HS; Jha V; Gupta KL; Sakhuja V
Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):647-9. PubMed ID: 11256238
[TBL] [Abstract][Full Text] [Related]
10. [A new strategy for monitoring levels of cyclosporin A in the blood of patients after kidney transplantation].
Halacová M; Jedlicková B; Průsa R
Ceska Slov Farm; 2003 Nov; 52(6):267-71. PubMed ID: 14661365
[TBL] [Abstract][Full Text] [Related]
11. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
[TBL] [Abstract][Full Text] [Related]
12. Total serum bile acids in renal transplanted patients receiving cyclosporine A.
Tripodi V; Nuñez M; Carducci C; Mamianetti A; Agost Carreño C
Clin Nephrol; 2002 Nov; 58(5):350-5. PubMed ID: 12425485
[TBL] [Abstract][Full Text] [Related]
13. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
[TBL] [Abstract][Full Text] [Related]
14. Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation.
Morton JM; Aboyoun CL; Malouf MA; Plit ML; Glanville AR
J Heart Lung Transplant; 2004 Sep; 23(9):1035-9. PubMed ID: 15454168
[TBL] [Abstract][Full Text] [Related]
15. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103.
Pescovitz MD; Wong RL; Choc MG; Chang CT
Clin Transplant; 1997 Oct; 11(5 Pt 1):442-5. PubMed ID: 9361938
[TBL] [Abstract][Full Text] [Related]
16. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M
Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
Hardy KW; Crocker JF; McLellan H; Goralski KB; Renton KW; Acott PD
J Clin Pharmacol; 2005 Feb; 45(2):161-7. PubMed ID: 15647408
[TBL] [Abstract][Full Text] [Related]
18. Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels.
Dominguez J; Gonzalez A; Crossley N; Norambuena R
Transplant Proc; 2004; 36(6):1655-8. PubMed ID: 15350442
[TBL] [Abstract][Full Text] [Related]
19. Long-term renal function in cyclosporine-treated renal allograft recipients.
Tanabe K; Novick AC; Streem S; Hodge E
Urology; 1995 Sep; 46(3):321-7. PubMed ID: 7660506
[TBL] [Abstract][Full Text] [Related]
20. Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients.
Covic A; Mardare N; Gusbeth-Tatomir P; Buhaescu I; Goldsmith DJ
Kidney Int; 2005 Feb; 67(2):732-7. PubMed ID: 15673323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
